Casein-derived peptide fragment (None established; individual peptides may have specific abbreviations (e.g., β-casomorphin, casoplatelin), but there is no universal abbreviation for the entire class.)

Casein-derived peptide fragments are short chains of amino acids produced during the digestion or fermentation of casein proteins found primarily in cow's milk. These bioactive peptides exhibit diverse physiological activities depending on their sequence and structure. Some act as natural inhibitors of enzymes like angiotensin-converting enzyme, contributing to blood pressure regulation; others mimic endogenous opioids and bind opioid receptors affecting pain perception; still others display antimicrobial properties by disrupting bacterial cell membranes or modulate inflammation through interference with cellular signaling pathways involved in chronic diseases such as cardiovascular disease and diabetes. Because they represent a large family rather than one discrete molecule or receptor, "casein-derived peptide fragment" is not suitable as an individual therapeutic target entry but instead refers collectively to many functionally distinct molecules derived from milk protein hydrolysis.

Other names

Casein hydrolysate peptidesMilk protein-derived bioactive peptidesCasomorphins (for opioid-like fragments)Casokinins (for antihypertensive fragments)Casoplatelins (for antithrombotic fragments)

Varies by fragment: - Inhibition of angiotensin-converting enzyme leading to blood pressure reduction ("casokinins"). - Binding to opioid receptors producing analgesic effects ("casomorphins"). - Inhibition of platelet aggregation ("casoplatelins"). - Disruption/permeabilization of bacterial membranes by binding lipoteichoic acid/lipopolysaccharide ("antimicrobial casein fragments"). - Modulation/inhibition of pro-inflammatory signaling pathways in immune cells ("anti-inflammatory casein peptides").